Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri; Department of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri.
Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.
J Urol. 2016 Aug;196(2):467-72. doi: 10.1016/j.juro.2016.02.2974. Epub 2016 Mar 17.
We compare the systemic (nonurological) symptoms between patients with overactive bladder and subjects without overactive bladder. We also compare the urinary symptoms, quality of life and psychosocial measures between the 2 subgroups of patients with overactive bladder with a high vs low systemic symptom burden.
Patients diagnosed with overactive bladder (51) and age matched individuals without overactive bladder (30) were administered the polysymptomatic, polysyndromic questionnaire to assess the numbers and distribution of systemic symptoms across multiple organ systems. Validated instruments were administered to evaluate urinary symptoms (ICIQ-UI, ICIQ-OAB, OAB-q, USS), quality of life (UDI-6, IIQ-7, OAB-q) and psychosocial difficulties (depression, anxiety, stress, sexual trauma, sleep, fatigue). Patients with overactive bladder were divided into 2 subgroups (with and without widespread systemic symptoms) and their responses were compared.
Patients with overactive bladder reported significantly more systemic (nonurological) symptoms compared to controls (mean ± SD 17.5 ± 12.3 vs 6.4 ± 7.9 symptoms, p <0.001). Differences were observed across multiple organ systems (neurologic, cardiopulmonary, gastrointestinal, sexual, musculoskeletal and gynecologic, p <0.05). About a third of patients with overactive bladder (31.4%) reported widespread systemic symptoms across multiple organ systems (mean 32.0 symptoms). The presence of widespread systemic symptoms among patients with overactive bladder was correlated with worse incontinence/overactive bladder symptoms (ICIQ-UI, OAB-q), poorer quality of life (UDI-6, IIQ-7, OAB-q) and more psychosocial difficulties (depression, anxiety, fatigue and higher stress, p <0.05).
The increased presence of nonurological symptoms in overactive bladder suggests an underlying systemic etiology and pathogenetic mechanisms that may contribute to overactive bladder. This study highlights the importance of understanding systemic factors in urological conditions otherwise thought to be organ specific.
我们比较了膀胱过度活动症患者和无膀胱过度活动症患者的全身(非泌尿系统)症状。我们还比较了两组膀胱过度活动症患者的泌尿系统症状、生活质量和心理社会指标,其中一组患者的全身症状负担较高,另一组患者的全身症状负担较低。
对 51 例被诊断为膀胱过度活动症的患者和 30 例年龄匹配的无膀胱过度活动症的个体进行了多系统症状的多症状、多综合征问卷评估,以评估多个器官系统的全身症状数量和分布。使用经过验证的工具评估了泌尿系统症状(ICIQ-UI、ICIQ-OAB、OAB-q、USS)、生活质量(UDI-6、IIQ-7、OAB-q)和心理社会困难(抑郁、焦虑、压力、性创伤、睡眠、疲劳)。将膀胱过度活动症患者分为两组(有广泛全身症状和无广泛全身症状),并比较他们的反应。
与对照组相比,膀胱过度活动症患者报告的全身(非泌尿系统)症状明显更多(平均±标准差 17.5±12.3 与 6.4±7.9 症状,p<0.001)。在多个器官系统(神经、心肺、胃肠道、性、肌肉骨骼和妇科,p<0.05)中观察到差异。大约三分之一的膀胱过度活动症患者(31.4%)报告了多个器官系统的广泛全身症状(平均 32.0 种症状)。膀胱过度活动症患者广泛全身症状的存在与更严重的失禁/膀胱过度活动症症状(ICIQ-UI、OAB-q)、更差的生活质量(UDI-6、IIQ-7、OAB-q)和更多的心理社会困难(抑郁、焦虑、疲劳和更高的压力,p<0.05)相关。
膀胱过度活动症中存在更多的非泌尿系统症状表明存在潜在的全身性病因和发病机制,这可能导致膀胱过度活动症。这项研究强调了在原本被认为是器官特异性的泌尿系统疾病中理解全身性因素的重要性。